You are here
China drugmaker in US$764m IPO
[HONG KONG] Luye Pharma Group, a Chinese drugmaker backed by Singapore's sovereign wealth fund, and the company's owners are poised to raise US$764 million from a Hong Kong initial public offering, people with knowledge of the matter said.
The company, based in eastern China's Yantai city
- CALL +65 6388 3838
- EMAIL email@example.com